CVS Health Corporation operates an integrated health care model that combines retail pharmacy, pharmacy benefit management, health insurance, medical clinics, specialty and mail pharmacy support, and related consumer health services. Recurring company news includes quarterly results and guidance, segment performance across Health Services, Health Care Benefits, and Pharmacy & Consumer Wellness, and capital returns through common-stock dividends.
Updates also cover CVS Caremark formulary decisions, biosimilar adoption, Aetna prior authorization and plan-administration initiatives, community health investments by the CVS Health Foundation, and developments involving Omnicare, the company's long-term care pharmacy subsidiary.
CVS Health (NYSE: CVS) announced that Shawn Guertin, Executive Vice President and Chief Financial Officer, will participate in a fireside chat with investors at the Goldman Sachs Global Healthcare Conference on June 15, 2022, at approximately 8:00 am Pacific Time. An audio webcast of this event will be available on the CVS Health Investor Relations website and archived for one year. CVS Health provides diverse health solutions, improving community health across America through a strong workforce and various services.
Aetna Better Health of Kansas, a CVS Health company, announced a donation of $125,000 to support community health initiatives across Kansas. This funding will assist five local organizations addressing critical health and social care needs, including mental health and housing. Since 2021, Aetna has contributed over $330,000 to various community organizations in the state. The aim of these donations is to enhance access to care and improve well-being for underserved populations in Kansas.
Summary not available.
Summary not available.
CVS Health (NYSE: CVS) announced that Executive Vice President and CFO Shawn Guertin will participate in a fireside chat at the Bank of America Healthcare Conference on May 12, 2022, at 8:40 am Pacific Time. The event will be available via an audio webcast on the Investor Relations section of the CVS Health website, where it will be archived for one year. CVS Health is a top health solutions company, emphasizing affordable health services and community engagement through over 300,000 employees.
CVS Health is offering no-cost heart health screenings at its MinuteClinic locations from May 8 to May 14, coinciding with National Women's Health Week. This initiative aims to educate women about cardiovascular disease, which is the leading cause of death among women. Alongside screenings, CVS will provide special offers on health products for ExtraCare Rewards members. The company continues its support for the American Heart Association's Go Red for Women movement through in-store fundraising from May 1 to May 28 to enhance awareness and resources for women's health.
CVS Health Corporation reported a strong performance for Q1 2022, with total revenues reaching $76.8 billion, a growth of 11.2% year-over-year. GAAP diluted EPS was $1.74, while adjusted EPS stood at $2.22, reflecting a $0.18 increase. The company generated $3.6 billion in cash flow from operations and announced a 10% dividend increase. However, operating income fell by 2.4% due to a legal settlement accrual for opioid claims valued at $484 million. Full-year adjusted EPS guidance was raised to $8.20 to $8.40.
CVS Health has completed the installation of time delay safe technology in all 97 CVS Pharmacy locations in Nevada. This initiative aims to reduce pharmacy robberies and the diversion of controlled substances, particularly opioids. Previous implementations in other states showed a 50-70% decrease in robberies. The company supports local law enforcement efforts against organized retail crime and has launched a Safe Medication Disposal Program across Nevada, collecting nearly 29,000 pounds of unwanted medications.
CVS Health has successfully installed time delay safe technology in all 198 CVS Pharmacy locations in Arizona. This initiative aims to reduce pharmacy robberies and prevent the diversion of controlled substances, including opioids. The time delay mechanism will electronically delay access to safes, enhancing safety for employees and customers. CVS had previously noted a 70% reduction in robberies in Indianapolis after introducing this technology. The rollout aligns with efforts to combat organized retail crime and complements CVS's ongoing community health initiatives.
Biofourmis has achieved unicorn status following a $300 million Series D investment led by General Atlantic, with participation from CVS Health and other investors. The funds will enhance Biofourmis' virtual care solutions, including personalized in-home care, and expand clinical trials for digital therapies. Former Medtronic CEO, Dr. Omar Ishrak, has been appointed Chairman of the Board. The company aims to strengthen its presence in the value-based care market, focusing on improving patient outcomes while reducing costs.